Cargando…

The prognostic value of CXC subfamily ligands in stage I-III patients with colorectal cancer

OBJECTIVE: To investigate the value of CXC subfamily ligands in stage I-III patients with colorectal cancer, in order to find a new predictor for CRC patients. METHODS: We used Gene Expression Omnibus (GEO) database to collect the gene expression of CXC subfamily ligands and corresponding clinical d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiangde, Zhong, Qiulu, Luo, Danjing, Du, Qinghua, Liu, Wenqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459597/ https://www.ncbi.nlm.nih.gov/pubmed/30973890 http://dx.doi.org/10.1371/journal.pone.0214611

Ejemplares similares

The efficacy of induction chemotherapy or adjuvant chemotherapy added to concurrent chemoradiotherapy in T3-4N0-1M0 nasopharyngeal carcinoma: a propensity score-matched analysis
por: Zhong, Qiulu, et al.
Publicado: (2023)

The prognostic value of inflammation markers in postoperative gliomas with or without adjuvant treatments
por: Luo, Yuanfu, et al.
Publicado: (2021)

The prognosis of gliomas with different molecular subtypes in the era of intensity-modulated radiation therapy (IMRT)
por: Zhong, Qiulu, et al.
Publicado: (2023)

The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue
por: Oladipo, O, et al.
Publicado: (2011)

Prognostic value of programmed death‐ligand 1 expression in patients with stage III colorectal cancer
por: Koganemaru, Shigehiro, et al.
Publicado: (2017)

The Role of Some Chemokines from the CXC Subfamily in a Mouse Model of Diabetic Neuropathy
por: Zychowska, Magdalena, et al.
Publicado: (2015)

Crosslinking-guided geometry of a complete CXC receptor-chemokine complex and the basis of chemokine subfamily selectivity
por: Ngo, Tony, et al.
Publicado: (2020)

The impact of radiation dose on the efficacy of definitive chemoradiotherapy in patients with locally advanced esophageal carcinoma: a systematic review and meta-analysis
por: Luo, Danjing, et al.
Publicado: (2022)

Comprehensive analysis of prognostic value and immune infiltration of CXC chemokines in pancreatic cancer
por: Jing, Yanhua, et al.
Publicado: (2022)

Cloning and bioactivity analysis of a CXC ligand in black seabream Acanthopagrus schlegeli: the evolutionary clues of ELR(+)CXC chemokines
por: Zhonghua, Cai, et al.
Publicado: (2008)

Prognostic value of the lymph node ratio in stage III colorectal cancer
por: Ren, Jing-Qing, et al.
Publicado: (2012)

CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer
por: Cabrero-de las Heras, Sara, et al.
Publicado: (2018)

The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients
por: Wang, Zhenglin, et al.
Publicado: (2015)

The prognostic value of CXC chemokine receptor 2 (CXCR2) in cancers: a meta-analysis
por: Qiao, Bingbing, et al.
Publicado: (2017)

Bioinformatics, Molecular Docking and Experiments In Vitro Analyze the Prognostic Value of CXC Chemokines in Breast Cancer
por: Wang, Fei, et al.
Publicado: (2021)

Function of Chemokine (CXC Motif) Ligand 12 in Periodontal Ligament Fibroblasts
por: Yashiro, Yuichi, et al.
Publicado: (2014)

Bioinformatics analysis of the role of CXC ligands in the microenvironment of head and neck tumor
por: Jing, Fengyang, et al.
Publicado: (2021)

Structural basis of CXC chemokine receptor 1 ligand binding and activation
por: Ishimoto, Naito, et al.
Publicado: (2023)

Prognostic Value of Lymphovascular Invasion in Patients with Stage III Colorectal Cancer: A Retrospective Study
por: Zhong, Jin-Wei, et al.
Publicado: (2019)

Prognostic and predictive value of radiomics signatures in stage I‐III colon cancer
por: Dai, Weixing, et al.
Publicado: (2020)

Prognostic Value of Radiotherapy and Chemotherapy in Stage I–III Merkel Cell Carcinoma
por: Bi, Aihong, et al.
Publicado: (2022)

The prognostic value of ADRA1 subfamily genes in gastric carcinoma
por: Wang, Tingan, et al.
Publicado: (2019)

ELR+ CXC chemokine expression in benign and malignant colorectal conditions
por: Rubie, Claudia, et al.
Publicado: (2008)

Tumor microbiome analysis provides prognostic value for patients with stage III colorectal cancer
por: Kim, Jae Hyun, et al.
Publicado: (2023)

Bioinformatics Analysis of Potential Therapeutic Targets and Prognostic Biomarkers amid CXC Chemokines in Ovarian Carcinoma Microenvironment
por: Jin, Yunfeng, et al.
Publicado: (2021)

A novel gene signature derived from the CXC subfamily of chemokine receptors predicts the prognosis and immune infiltration of patients with lung adenocarcinoma
por: Deng, Kun, et al.
Publicado: (2022)

Prognostic significance of preoperative prognostic immune and nutritional index in patients with stage I–III colorectal cancer
por: Xie, Hailun, et al.
Publicado: (2022)

Mechanism of Cxc Chemokine Ligand 5 (CXCL5)/Cxc Chemokine Receptor 2 (CXCR2) Bio-Axis in Mice with Acute Respiratory Distress Syndrome
por: Wang, Chang-yong, et al.
Publicado: (2019)

The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2018)

Comprehensive analysis of the prognosis and immune infiltration for CXC chemokines in colorectal cancer
por: Yang, Xi, et al.
Publicado: (2021)

The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature
por: Korbecki, Jan, et al.
Publicado: (2021)

Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
por: Huang, Jiacheng, et al.
Publicado: (2021)

Prognostic Significance and Therapeutic Target of CXC Chemokines in the Microenvironment of Lung Adenocarcinoma
por: Wang, Kun, et al.
Publicado: (2022)

Nuclear TEAD4 with SIX1 Overexpression is an Independent Prognostic Marker in the Stage I–III Colorectal Cancer
por: Yu, Tong, et al.
Publicado: (2021)

Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer
por: Fountzilas, Elena, et al.
Publicado: (2018)

Prognostic value of a modified Immunoscore in patients with stage I−III resectable colon cancer
por: Zhao, Ke, et al.
Publicado: (2021)

Prognostic and predictive value of extended RAS mutation and mismatch repair status in stage III colorectal cancer
por: Sasaki, Yusuke, et al.
Publicado: (2016)

CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
por: Zhou, Xuezhi, et al.
Publicado: (2021)

Analysis of therapeutic targets and prognostic biomarkers of CXC chemokines in cervical cancer microenvironment
por: Kong, Weina, et al.
Publicado: (2021)

CXC ELR-Positive Chemokines as Diagnostic and Prognostic Markers for Breast Cancer Patients
por: Motyka, Joanna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mt8ganujpcte0mut3719cm1g98